Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/24/25 18:16 | 11/21/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Newhall Charles W III | MD | D | 2 | M.d | 1,464 | 36.60 | 0 | 40 | 50 | 120 | D | |||||||||||||||
10/10/25 17:33 | 10/9/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Khattar Jack A. | MD | DO | P,CEO | 17 | M.d | 13,713 | 29.93 | 0 | 458 | 26 | 2,212 | D | ||||||||||||||
10/10/25 17:33 | 10/9/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Khattar Jack A. | MD | DO | P,CEO | 17 | S.d | -13,713 | 29.93 | 0 | -458 | 2,212 | D | |||||||||||||||
9/26/25 16:17 | 9/25/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Rubin Jonathan | MD | O | SVP,Chie | 1 | M.d | 0 | 0.00 | 0 | 2 | 21 | 11 | D | ||||||||||||||
9/15/25 17:39 | 9/12/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Mottola Frank | MD | O | SVP,Chie | 2 | M.d | 426 | 42.64 | 0 | 10 | 182 | 15 | D | ||||||||||||||
9/15/25 17:39 | 9/12/25 | SUPN | Health | Drug | Pharmaceutical Preparations | Mottola Frank | MD | O | SVP,Chie | 2 | S.d | -426 | 42.64 | 0 | -10 | 15 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |